Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
17.04. | bioAffinity Technologies optimiert Lungenkrebs-Erkennungstest | 1 | Investing.com Deutsch | ||
17.04. | bioAffinity Technologies streamlines lung cancer detection test | 1 | Investing.com | ||
17.04. | RedChip Companies, Inc.: ASP Isotopes and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 254 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / April 17, 2025 / RedChip Companies will air interviews with ASP Isotopes Inc. (NASDAQ:ASPI) and bioAffinity Technologies, Inc. (NASDAQ:BIAF) on the RedChip Small Stocks... ► Artikel lesen | |
14.04. | bioAffinity Technologies, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
11.04. | bioAffinity Technologies, Inc. - S-1, General form for registration of securities | 2 | SEC Filings | ||
31.03. | bioAffinity Technologies, Inc. - 10-K, Annual Report | 3 | SEC Filings | ||
31.03. | bioAffinity posts 270% revenue rise with Medicare coverage | 11 | Investing.com | ||
31.03. | bioAffinity Technologies, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
BIOAFFINITY TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
28.03. | RedChip Companies, Inc.: bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 271 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / March 28, 2025 / RedChip Companies will air interviews with bioAffinity Technologies, Inc. (Nasdaq:BIAF) and Can-Fite BioPharma Ltd. (NYSE American:CANF) on the... ► Artikel lesen | |
07.03. | bioAffinity Technologies, Inc. - 8-K, Current Report | - | SEC Filings | ||
06.03. | bioAffinity kündigt Kostensenkungen zur Steigerung der CyPath Lung-Verkäufe an | 2 | Investing.com Deutsch | ||
06.03. | bioAffinity announces cost cuts to boost CyPath Lung sales | 1 | Investing.com | ||
27.02. | bioAffinity Technologies, Inc. - 8-K, Current Report | - | SEC Filings | ||
07.02. | bioAffinity Technologies, Inc. - 8-K, Current Report | - | SEC Filings | ||
14.01. | bioAffinity Technologies, Inc. - 8-K, Current Report | - | SEC Filings | ||
10.01. | Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 348 | ACCESS Newswire | ORLANDO, FL / ACCESSWIRE / January 10, 2025 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and bioAffinity Technologies, Inc. (Nasdaq:BIAF) on the RedChip Small... ► Artikel lesen | |
23.12.24 | bioAffinity Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
27.11.24 | bioAffinity Technologies, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
14.11.24 | bioAffinity Technologies GAAP EPS of -$0.16 misses by $0.01, revenue of $2.35M misses by $0.19M | 3 | Seeking Alpha | ||
14.11.24 | bioAffinity Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PALATIN TECHNOLOGIES | 0,182 | +5,69 % | Palatin's Phase 2 Obesity Study Shows Encouraging Appetite Suppression Data, Stock Up In Pre-Market | WASHINGTON (dpa-AFX) - Palatin Technologies, Inc. (PTN), Thursday announced results from its BMT-801 Phase 2 obesity study, which evaluated the co-administration of melanocortin 4 receptor or... ► Artikel lesen | |
BIOXXMED | 0,412 | +0,49 % | XETR DELETION OF INSTRUMENTS FROM XETRA - 31.03.2025 | The following instruments on Xetra do have their last trading day on 31.03.2025.Die folgenden Instrumente auf Xetra haben ihren letzten Handelstag am 31.03.2025.ISIN NameDE000A4BGGE4 bioXXmed AG ► Artikel lesen | |
VIVOSIM LABS | 1,930 | -100,00 % | VivoSim Labs, INC. - 8-K, Current Report | ||
OCUGEN | 0,646 | +2,02 % | Ocugen Aktie: Leichte Erholung nach schwierigem Jahr | Trotz langfristiger Verluste halten Analysten an positiven Bewertungen für Ocugen fest. Die Gentherapie-Pipeline bleibt der zentrale Hoffnungsträger. Die Ocugen-Aktie zeigt heute eine leichte Erholung... ► Artikel lesen | |
SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem unterzeichnet strategische Beteiligungsvereinbarung und gründet neues Joint Venture mit Promura GmbH | Vancouver, British Columbia - 22. April 2025 / IRW-Press / Sirona Biochem Corp. (TSX-V: SBM) (FWB: ZSB) (OTC:
SRBCF) ("Sirona"), ein Biotechnologieunternehmen, das auf kosmetische Inhaltsstoffe... ► Artikel lesen | |
BIO-GATE | 0,815 | -8,94 % | Bio-Gate startet Produkt-Launch für Tierpflege in den USA | Bio-Gate hat die Präsenz im nordamerikanischen Veterinärmarkt ausgebaut. Gemeinsam mit einem internationalen Anbieter bringt Bio-Gate neue Tierpflegeprodukte zur Haut-, Ohr- und Wundbehandlung in die... ► Artikel lesen | |
DEFENCE THERAPEUTICS | 0,530 | -6,03 % | Das ist die Nach-Oster-Chance! Evotec, Bayer, BioNTech, Defence Therapeutics und im Fokus | Donald Trump brüskiert seine internationalen Partner, beleidigt namhafte Amerikaner und entzieht Harvard langjährig zugesagte Fördermittel. Wer hätte das gedacht? Die neue US-Regentschaft entpuppt sich... ► Artikel lesen | |
VAXART | 0,312 | +2,64 % | Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | SOUTH SAN FRANCISCO, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" or "Vaxart") today announced that on March 24, 2025, the independent members of the Board... ► Artikel lesen | |
BURCON NUTRASCIENCE | 0,058 | 0,00 % | Burcon NutraScience Corporation: Burcon Integrates Protein Technologies at Galesburg Facility | Vancouver, British Columbia--(Newsfile Corp. - April 1, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of... ► Artikel lesen | |
CELLECTAR BIOSCIENCES | 0,270 | -1,46 % | Cellectar Biosciences: Multibagger mit Ansage? | Cellectar Biosciences (WKN: A3DQSD) heißt unsere Top-Spekulation der Stunde. Das auf Radiopharmaka gegen Krebs spezialisierte Biotechunternehmen konnte gestern eine wichtige Einigung mit der US-Gesundheitsbehörde... ► Artikel lesen | |
AFFIMED | 0,530 | -100,00 % | Affimed N.V.: Affimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement | MANNHEIM, Germany, April 21, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer,... ► Artikel lesen | |
IMMUNIC | 0,938 | -3,89 % | EQS-News: Immunic AG: Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments | Issuer: Immunic AG
/ Key word(s): Financing
Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
10.04.2025 / 19:00 CET/CEST
The... ► Artikel lesen | |
AIM IMMUNOTECH | 0,073 | -100,00 % | AIM ImmunoTech Inc.: AIM ImmunoTech Announces Trading Under the Ticker AIMI on the Pink Open Market | OCALA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. ("AIM" or the "Company") (OTC Pink: AIMI) - an immuno-pharma company focused on the research and development of therapeutics to... ► Artikel lesen | |
GINKGO BIOWORKS | 6,400 | -4,48 % | Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results | Ginkgo provides update on its restructuring process including significant improvement in cash flow in the fourth quarter, completion of site consolidation and an... ► Artikel lesen | |
T2 BIOSYSTEMS | 0,078 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.02.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 20.02.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.02.2025.ISIN NameCA24703H1029 DELIVRA... ► Artikel lesen |